SlideShare a Scribd company logo
1 of 5
Download to read offline
6th
Semester (BP 604T) Biopharmaceutics & Pharmacokinetics
22
working space, storage area,
machinery and equipments,
standard operating procedures,
health and hygiene,
documentation and records.
machinery and equipments,
standard operating procedures,
health and hygiene,
documentation and records.
RAJIV GANDHI UNIVERSITY OF HEALTH SCIENCES, BANGALORE
SIXTH SEMESTER
BP 604T. BIO PHARMACEUTICS AND PHARMACOKINETICS
Learning objectives: Upon completion of the course student shall be able to:
1. To understand the basic concepts in bio-pharmaceutics and pharmacokinetics and their significance
2. Use of plasma drug concentration-time data to calculate the pharmacokinetic parameters to describe the kinetics
of drug absorption, distribution, metabolism, excretion and elimination.
3. To understand the concepts of bioavailability and bioequivalence of drug products and their significance.
4. To Understand various pharmacokinetic parameters, their significance and applications
BP 604T. BIO PHARMACEUTICS AND PHARMACOKINETICS (BLUE PRINT)
6th
Semester (BP 604T) Biopharmaceutics & Pharmacokinetics
23
Sl.No Chapter
Marks Distribution Total
Must Know Desirable to know Long
essay
Short
essay
Short
Answer
Unit-I
Introduction to Bio
pharmaceutics
Absorption; Mechanism of drug
absorption through GIT, factors
influencing drug absorption
though GIT, absorption of drug
from Non per oral extra-vascular
routes,
Distribution: Tissue permeability
of drugs, binding of drugs,
apparent volume of drug
distribution, plasma and tissue
protein binding of drugs, factors
affecting protein-drug binding.
Kinetics of protein binding,
Clinical significance of protein
binding of drugs
Absorption: Mechanism of
drug absorption through GIT,
factors influencing drug
absorption though GIT,
absorption of drug from
Distribution: Tissue
permeability of drugs, binding
of drugs, apparent volume of
drug distribution, plasma and
tissue protein binding of drugs,
factors affecting protein-drug
binding.
Non per oral extra-
vascular routes, Kinetics
of protein binding,
Clinical Significance of
protein binding of drugs
extra-vascular routes,
Protein binding of drugs
10 5+5 2+2 24M
6th
Semester (BP 604T) Biopharmaceutics & Pharmacokinetics
24
Unit-II
Elimination: Drug metabolism
and basic understanding metabolic
pathways renal excretion of drugs,
factors affecting renal excretion of
drugs, renal clearance, Non renal
routes of drug excretion of drugs
Bioavailability and
Bioequivalence: Definition and
Objectives of bioavailability,
absolute and relative
bioavailability, measurement of
bioavailability, in-vitro drug
dissolution models, in-vitro-in-
vivo correlations, bioequivalence
studies, methods to enhance the
dissolution rates and
bioavailability of poorly soluble
drugs.
Elimination: Drug metabolism
and basic understanding
metabolic pathways renal
excretion of drugs, factors
affecting renal excretion of
drugs.
Bioavailability and
Bioequivalence:
Absolute and relative
bioavailability, measurement of
bioavailability,
Methods to enhance the
dissolution rates and
bioavailability of poorly soluble
drugs.
Renal clearance, Non
renal routes of drug
excretion of drugs. In-
vitro drug dissolution
models, in-vitro-in-vivo
correlations,
bioequivalence studies,
Poorly soluble drugs
10 5+5 2+2 24M
Unit-III
Pharmacokinetics: Definition
and introduction to
Pharmacokinetics, Compartment
models, Non compartment
Pharmacokinetics
Definition, Introduction to
Pharmacokinetics,
Compartment models, Non
Pharmacokinetics
parameters- KE , t1/2,
Vd, AUC, Ka, Clt and
CLR- definitions Methods
10 5+5 2+2 24M
6th
Semester (BP 604T) Biopharmaceutics & Pharmacokinetics
25
models, physiological models,
One compartment open model.
(a). Intravenous Injection (Bolus)
(b). Intravenous infusion and (c)
Extra vascular administrations.
Pharmacokinetics parameters- KE
, t1/2, Vd, AUC, Ka, Clt and CLR-
definitions methods of
eliminations, understanding of
their significance and application
compartment models,
physiological models, One
compartment open model.
(a). Intravenous Injection
(Bolus) (b). Intravenous
infusion and (c) Extra vascular
administrations.
of eliminations,
understanding of their
significance and
application
Understanding
significance of
pharmacokinetics and
application
Unit-IV
Multicompartment models: Two
compartment open model. IV
bolus Kinetics of multiple dosing,
steady state drug levels,
calculation of loading and
maintenance doses and their
significance in clinical setting.
Multi Compartment Models:
Two compartment open model.
IV bolus Kinetics of multiple
dosing, steady state drug levels,
Calculation of loading
and maintenance doses
Significance in clinical
setting.
--- 5 2+2 09M
Unit-V
Nonlinear Pharmacokinetics: a.
Introduction, b. Factors causing
Non-linearity. c. Michaelis-
menton method of estimating
parameters, Explanation with
Nonlinear Pharmacokinetics:
a. Introduction, b. Factors
causing Non-linearity. c.
Michaelis-menton
Method of estimating
parameters. Explanation
with example of drugs.
--- 5+5 2+2 14M
6th
Semester (BP 604T) Biopharmaceutics & Pharmacokinetics
26
example of drugs.
Total 30 45 20 95M

More Related Content

Similar to 6th Sem BPharm.pdf

New drug discovery and development (Part - 1)
New drug discovery and development (Part - 1)New drug discovery and development (Part - 1)
New drug discovery and development (Part - 1)swatisejwani
 
Computational modeling in_drug_disposition[1]
Computational modeling in_drug_disposition[1]Computational modeling in_drug_disposition[1]
Computational modeling in_drug_disposition[1]NikitaGidde
 
Bioavability and Bioequalance
Bioavability and BioequalanceBioavability and Bioequalance
Bioavability and BioequalanceManojSrivastava66
 
Introduction to the drug discovery process
Introduction to the drug discovery processIntroduction to the drug discovery process
Introduction to the drug discovery processThanh Truong
 
drug discovery.pptx
drug discovery.pptxdrug discovery.pptx
drug discovery.pptxvineetarun1
 
Practical biopharmaceutics 1.pptx
Practical biopharmaceutics 1.pptxPractical biopharmaceutics 1.pptx
Practical biopharmaceutics 1.pptxssuser1e0c4e
 
purpose of bioavailability studies.pdf
purpose of bioavailability studies.pdfpurpose of bioavailability studies.pdf
purpose of bioavailability studies.pdfsukesh ydv
 
Bioinformatics in drug discovery
Bioinformatics in drug discoveryBioinformatics in drug discovery
Bioinformatics in drug discoveryKAUSHAL SAHU
 
Bioavailability and bioequivalance
Bioavailability and bioequivalanceBioavailability and bioequivalance
Bioavailability and bioequivalanceRavi Kiran
 
BIOAVAILABILITY AND BIOEQUIVALENCE
BIOAVAILABILITY AND BIOEQUIVALENCEBIOAVAILABILITY AND BIOEQUIVALENCE
BIOAVAILABILITY AND BIOEQUIVALENCEAVIJIT BAKSHI
 
Pharmacotherapeutics
PharmacotherapeuticsPharmacotherapeutics
Pharmacotherapeuticsatharshamim
 
Applications of Bio pharmaceutics siam
Applications of Bio pharmaceutics siamApplications of Bio pharmaceutics siam
Applications of Bio pharmaceutics siamKamruzzaman Siam
 
Application of biopharmaceutics in pharmaceutical field.siam(ppt file)
Application of biopharmaceutics in pharmaceutical field.siam(ppt file)Application of biopharmaceutics in pharmaceutical field.siam(ppt file)
Application of biopharmaceutics in pharmaceutical field.siam(ppt file)Kamruzzaman Siam
 
Application of biopharmaceutics in pharmaceutical field.siam(pdf file)
Application of biopharmaceutics in pharmaceutical field.siam(pdf file)Application of biopharmaceutics in pharmaceutical field.siam(pdf file)
Application of biopharmaceutics in pharmaceutical field.siam(pdf file)Kamruzzaman Siam
 

Similar to 6th Sem BPharm.pdf (20)

New drug discovery and development (Part - 1)
New drug discovery and development (Part - 1)New drug discovery and development (Part - 1)
New drug discovery and development (Part - 1)
 
Computational modeling in_drug_disposition[1]
Computational modeling in_drug_disposition[1]Computational modeling in_drug_disposition[1]
Computational modeling in_drug_disposition[1]
 
Prodrug Design.pptx
Prodrug Design.pptxProdrug Design.pptx
Prodrug Design.pptx
 
Introduction to Pharmacology
Introduction to PharmacologyIntroduction to Pharmacology
Introduction to Pharmacology
 
Bioavability and Bioequalance
Bioavability and BioequalanceBioavability and Bioequalance
Bioavability and Bioequalance
 
Introduction to the drug discovery process
Introduction to the drug discovery processIntroduction to the drug discovery process
Introduction to the drug discovery process
 
drug discovery.pptx
drug discovery.pptxdrug discovery.pptx
drug discovery.pptx
 
Practical biopharmaceutics 1.pptx
Practical biopharmaceutics 1.pptxPractical biopharmaceutics 1.pptx
Practical biopharmaceutics 1.pptx
 
test
testtest
test
 
Bioavailability Studies
Bioavailability StudiesBioavailability Studies
Bioavailability Studies
 
purpose of bioavailability studies.pdf
purpose of bioavailability studies.pdfpurpose of bioavailability studies.pdf
purpose of bioavailability studies.pdf
 
Bioinformatics in drug discovery
Bioinformatics in drug discoveryBioinformatics in drug discovery
Bioinformatics in drug discovery
 
Bioavailability and bioequivalance
Bioavailability and bioequivalanceBioavailability and bioequivalance
Bioavailability and bioequivalance
 
BIOAVAILABILITY AND BIOEQUIVALENCE
BIOAVAILABILITY AND BIOEQUIVALENCEBIOAVAILABILITY AND BIOEQUIVALENCE
BIOAVAILABILITY AND BIOEQUIVALENCE
 
Pharmacotherapeutics
PharmacotherapeuticsPharmacotherapeutics
Pharmacotherapeutics
 
Herbal formulation
Herbal formulationHerbal formulation
Herbal formulation
 
Applications of Bio pharmaceutics siam
Applications of Bio pharmaceutics siamApplications of Bio pharmaceutics siam
Applications of Bio pharmaceutics siam
 
Application of biopharmaceutics in pharmaceutical field.siam(ppt file)
Application of biopharmaceutics in pharmaceutical field.siam(ppt file)Application of biopharmaceutics in pharmaceutical field.siam(ppt file)
Application of biopharmaceutics in pharmaceutical field.siam(ppt file)
 
Application of biopharmaceutics in pharmaceutical field.siam(pdf file)
Application of biopharmaceutics in pharmaceutical field.siam(pdf file)Application of biopharmaceutics in pharmaceutical field.siam(pdf file)
Application of biopharmaceutics in pharmaceutical field.siam(pdf file)
 
Lectures 11 Bioavailability
Lectures 11 BioavailabilityLectures 11 Bioavailability
Lectures 11 Bioavailability
 

Recently uploaded

Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfciinovamais
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104misteraugie
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfchloefrazer622
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformChameera Dedduwage
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)eniolaolutunde
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdfSoniaTolstoy
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxVishalSingh1417
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDThiyagu K
 
Disha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdfDisha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdfchloefrazer622
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...christianmathematics
 
General AI for Medical Educators April 2024
General AI for Medical Educators April 2024General AI for Medical Educators April 2024
General AI for Medical Educators April 2024Janet Corral
 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Disha Kariya
 
IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...
IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...
IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...PsychoTech Services
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3JemimahLaneBuaron
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 

Recently uploaded (20)

Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdf
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy Reform
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 
Disha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdfDisha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdf
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
General AI for Medical Educators April 2024
General AI for Medical Educators April 2024General AI for Medical Educators April 2024
General AI for Medical Educators April 2024
 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..
 
IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...
IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...
IGNOU MSCCFT and PGDCFT Exam Question Pattern: MCFT003 Counselling and Family...
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 

6th Sem BPharm.pdf

  • 1. 6th Semester (BP 604T) Biopharmaceutics & Pharmacokinetics 22 working space, storage area, machinery and equipments, standard operating procedures, health and hygiene, documentation and records. machinery and equipments, standard operating procedures, health and hygiene, documentation and records. RAJIV GANDHI UNIVERSITY OF HEALTH SCIENCES, BANGALORE SIXTH SEMESTER BP 604T. BIO PHARMACEUTICS AND PHARMACOKINETICS Learning objectives: Upon completion of the course student shall be able to: 1. To understand the basic concepts in bio-pharmaceutics and pharmacokinetics and their significance 2. Use of plasma drug concentration-time data to calculate the pharmacokinetic parameters to describe the kinetics of drug absorption, distribution, metabolism, excretion and elimination. 3. To understand the concepts of bioavailability and bioequivalence of drug products and their significance. 4. To Understand various pharmacokinetic parameters, their significance and applications BP 604T. BIO PHARMACEUTICS AND PHARMACOKINETICS (BLUE PRINT)
  • 2. 6th Semester (BP 604T) Biopharmaceutics & Pharmacokinetics 23 Sl.No Chapter Marks Distribution Total Must Know Desirable to know Long essay Short essay Short Answer Unit-I Introduction to Bio pharmaceutics Absorption; Mechanism of drug absorption through GIT, factors influencing drug absorption though GIT, absorption of drug from Non per oral extra-vascular routes, Distribution: Tissue permeability of drugs, binding of drugs, apparent volume of drug distribution, plasma and tissue protein binding of drugs, factors affecting protein-drug binding. Kinetics of protein binding, Clinical significance of protein binding of drugs Absorption: Mechanism of drug absorption through GIT, factors influencing drug absorption though GIT, absorption of drug from Distribution: Tissue permeability of drugs, binding of drugs, apparent volume of drug distribution, plasma and tissue protein binding of drugs, factors affecting protein-drug binding. Non per oral extra- vascular routes, Kinetics of protein binding, Clinical Significance of protein binding of drugs extra-vascular routes, Protein binding of drugs 10 5+5 2+2 24M
  • 3. 6th Semester (BP 604T) Biopharmaceutics & Pharmacokinetics 24 Unit-II Elimination: Drug metabolism and basic understanding metabolic pathways renal excretion of drugs, factors affecting renal excretion of drugs, renal clearance, Non renal routes of drug excretion of drugs Bioavailability and Bioequivalence: Definition and Objectives of bioavailability, absolute and relative bioavailability, measurement of bioavailability, in-vitro drug dissolution models, in-vitro-in- vivo correlations, bioequivalence studies, methods to enhance the dissolution rates and bioavailability of poorly soluble drugs. Elimination: Drug metabolism and basic understanding metabolic pathways renal excretion of drugs, factors affecting renal excretion of drugs. Bioavailability and Bioequivalence: Absolute and relative bioavailability, measurement of bioavailability, Methods to enhance the dissolution rates and bioavailability of poorly soluble drugs. Renal clearance, Non renal routes of drug excretion of drugs. In- vitro drug dissolution models, in-vitro-in-vivo correlations, bioequivalence studies, Poorly soluble drugs 10 5+5 2+2 24M Unit-III Pharmacokinetics: Definition and introduction to Pharmacokinetics, Compartment models, Non compartment Pharmacokinetics Definition, Introduction to Pharmacokinetics, Compartment models, Non Pharmacokinetics parameters- KE , t1/2, Vd, AUC, Ka, Clt and CLR- definitions Methods 10 5+5 2+2 24M
  • 4. 6th Semester (BP 604T) Biopharmaceutics & Pharmacokinetics 25 models, physiological models, One compartment open model. (a). Intravenous Injection (Bolus) (b). Intravenous infusion and (c) Extra vascular administrations. Pharmacokinetics parameters- KE , t1/2, Vd, AUC, Ka, Clt and CLR- definitions methods of eliminations, understanding of their significance and application compartment models, physiological models, One compartment open model. (a). Intravenous Injection (Bolus) (b). Intravenous infusion and (c) Extra vascular administrations. of eliminations, understanding of their significance and application Understanding significance of pharmacokinetics and application Unit-IV Multicompartment models: Two compartment open model. IV bolus Kinetics of multiple dosing, steady state drug levels, calculation of loading and maintenance doses and their significance in clinical setting. Multi Compartment Models: Two compartment open model. IV bolus Kinetics of multiple dosing, steady state drug levels, Calculation of loading and maintenance doses Significance in clinical setting. --- 5 2+2 09M Unit-V Nonlinear Pharmacokinetics: a. Introduction, b. Factors causing Non-linearity. c. Michaelis- menton method of estimating parameters, Explanation with Nonlinear Pharmacokinetics: a. Introduction, b. Factors causing Non-linearity. c. Michaelis-menton Method of estimating parameters. Explanation with example of drugs. --- 5+5 2+2 14M
  • 5. 6th Semester (BP 604T) Biopharmaceutics & Pharmacokinetics 26 example of drugs. Total 30 45 20 95M